Company | Name | Exchange | Sector | Industry | Market Cap | P/E Ratio | PEG Ratio | Last Trade Price | Day Change (%) | Fair Value | Fair Value Upside | Fair Value Label | Analyst Price Target | Analyst Target Upside | Overall Health |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Amazoncom | Frankfurt | Consumer Cyclicals | Diversified Retail | €2.42T | 50x | 0.35 | €228.80 | 0.9% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Amazon.Com | Xetra | Consumer Cyclicals | Diversified Retail | €2.42T | 50x | 0.35 | €228.95 | 1.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Alphabet | Xetra | Technology | Software & IT Services | €2.27T | 23.8x | 0.6 | €185.72 | 1.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Alphabet A | Xetra | Technology | Software & IT Services | €2.27T | 23.8x | 0.6 | €183.96 | 1.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Alphabet | Frankfurt | Technology | Software & IT Services | €2.27T | 23.8x | 0.6 | €185.88 | 0.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Alphabet A | Frankfurt | Technology | Software & IT Services | €2.27T | 23.8x | 0.6 | €184.40 | 1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Eli Lilly and | Xetra | Healthcare | Pharmaceuticals | €758.16B | 94.1x | 1.29 | €848.50 | 5.8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Eli Lilly and | Frankfurt | Healthcare | Pharmaceuticals | €758.16B | 94.1x | 1.29 | €835.80 | 3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Novo Nordisk A S | Xetra | Healthcare | Pharmaceuticals | €376.53B | 27.6x | 1.06 | €84.99 | 1.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Novo Nordisk A S | Frankfurt | Healthcare | Pharmaceuticals | €376.53B | 27.6x | 1.06 | €84.13 | 0.9% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Hermes International SCA | Frankfurt | Consumer Cyclicals | Textiles & Apparel | €290.10B | 64.9x | 5.1 | €2,767 | 1.8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Cocala | Xetra | Consumer Non-Cyclicals | Beverages | €262.51B | 26.3x | -10.72 | €60.87 | 0.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Cocala | Frankfurt | Consumer Non-Cyclicals | Beverages | €262.51B | 26.3x | -10.72 | €60.80 | 0.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Cisco | Xetra | Technology | Communications & Networking | €238.79B | 26.7x | -0.87 | €60.13 | 0.9% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Cisco Systems | Frankfurt | Technology | Communications & Networking | €238.79B | 26.7x | -0.87 | €60 | 2.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Palantir Technologies | Xetra | Technology | Software & IT Services | €236.74B | 527.4x | 2.07 | €103.70 | 8.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
AstraZeneca | Frankfurt | Healthcare | Pharmaceuticals | €219.84B | 35.1x | 3.43 | €142.35 | 6.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Astrazeneca PLC | Xetra | Healthcare | Pharmaceuticals | €219.84B | 35.1x | 3.43 | €141.95 | 5.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
AstraZeneca DRC | Frankfurt | Healthcare | Pharmaceuticals | €219.84B | 35.1x | 3.43 | €71.50 | 8.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Merck | Frankfurt | Healthcare | Pharmaceuticals | €216.74B | 13.2x | 0.12 | €85.50 | 0.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Merck | Xetra | Healthcare | Pharmaceuticals | €216.69B | 13.2x | 0.12 | €85.40 | -0.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Alibaba | Frankfurt | Technology | Software & IT Services | €216.29B | 18x | -0.59 | €96.90 | 1.8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Alibaba DRC | Xetra | Technology | Software & IT Services | €216.29B | 18x | -0.59 | €97.20 | 1.8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Philip Morris International | Frankfurt | Consumer Non-Cyclicals | Food & Tobacco | €216.07B | 22.9x | 0.92 | €138.88 | 10.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Nestle DRC | Frankfurt | Consumer Non-Cyclicals | Food & Tobacco | €212.51B | 18.2x | 0.98 | €82.40 | -0.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Linde | Frankfurt | Basic Materials | Chemicals | €207.70B | 34.5x | 3.72 | €440.40 | 1.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 12.3% Upside | Upgrade to Pro+ | |
Linde PLC | Xetra | Basic Materials | Chemicals | €207.70B | 34.5x | 3.72 | €437.40 | 0.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 12.6% Upside | Upgrade to Pro+ | |
McDonald’s | Frankfurt | Consumer Cyclicals | Hotels & Entertainment Services | €202.37B | 25.6x | 63.04 | €283 | 2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
McDonald's | Xetra | Consumer Cyclicals | Hotels & Entertainment Services | €202.37B | 25.6x | 63.04 | €283.70 | 2.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Walt Disney | Xetra | Consumer Cyclicals | Media & Publishing | €193.56B | 36x | 0.37 | €106.54 | -0.9% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Walt Disney | Frankfurt | Consumer Cyclicals | Media & Publishing | €193.56B | 36x | 0.37 | €106.94 | -0.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
PepsiCo | Frankfurt | Consumer Non-Cyclicals | Beverages | €192.10B | 20.8x | 1.71 | €139.10 | 0.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Pepsico | Xetra | Consumer Non-Cyclicals | Beverages | €192.02B | 20.8x | 1.71 | €139.38 | 0.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
L’Oreal | Xetra | Consumer Non-Cyclicals | Personal & Household Products & Services | €189.11B | 29.1x | 2.61 | €353.25 | 2.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
L’Oreal | Frankfurt | Consumer Non-Cyclicals | Personal & Household Products & Services | €189.11B | 29.1x | 2.61 | €344 | -0.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Qualcomm | Frankfurt | Technology | Semiconductors & Semiconductor Equipment | €178.80B | 18.5x | 0.48 | €161.44 | -3.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Qualcomm | Xetra | Technology | Semiconductors & Semiconductor Equipment | €178.80B | 18.5x | 0.48 | €161.68 | -2.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Advanced Micro Devices | Xetra | Technology | Semiconductors & Semiconductor Equipment | €173.35B | 109.8x | 0.12 | €106.12 | 1.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Advanced Micro Devices | Frankfurt | Technology | Semiconductors & Semiconductor Equipment | €173.35B | 109.8x | 0.12 | €106.34 | -1.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Commonwealth Bank of Australia | Frankfurt | Financials | Banking Services | €164.64B | 17.9x | -7.89 | €97.64 | 1.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Siemens AG DRC | Frankfurt | Industrials | Machinery, Tools, Heavy Vehicles, Trains & Ships | €163.37B | 19.8x | 4.2 | €102 | 3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Siemens N | Xetra | Industrials | Machinery, Tools, Heavy Vehicles, Trains & Ships | €163.37B | 19.8x | 4.2 | €208.05 | 3.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 5% Upside | Upgrade to Pro+ | |
Siemens | Frankfurt | Industrials | Machinery, Tools, Heavy Vehicles, Trains & Ships | €163.37B | 19.8x | 4.2 | €207.65 | 3.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 5.1% Upside | Upgrade to Pro+ | |
Amgen | Xetra | Healthcare | Pharmaceuticals | €155.53B | 39.5x | -0.82 | €289.50 | -0.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Amgen | Frankfurt | Healthcare | Pharmaceuticals | €155.29B | 39.5x | -0.82 | €290 | 5.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
S&P Global | Frankfurt | Industrials | Professional & Commercial Services | €154.89B | 45.8x | 0.98 | €499.95 | 2.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Shopify | Frankfurt | Technology | Software & IT Services | €147.39B | 110.8x | 0.5 | €115.20 | 0.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Applied Materials | Xetra | Technology | Semiconductors & Semiconductor Equipment | €142.54B | 21x | 3.31 | €174.40 | 1.9% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Applied Materials | Frankfurt | Technology | Semiconductors & Semiconductor Equipment | €142.54B | 21x | 3.31 | €176 | 4.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Pfizer | Frankfurt | Healthcare | Pharmaceuticals | €141.41B | 18.3x | -0.59 | €24.97 | -2.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ |